Display options
Cite
Gevrek F, Erdemir F. Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique. Turk J Urol. 2018;44(1):16-23doi: 10.5152/tud.2017.95752.
Gevrek, F., & Erdemir, F. (2018). Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique. Turkish journal of urology, 44(1), 16-23. https://doi.org/10.5152/tud.2017.95752
Gevrek, Fikret, and Erdemir, Fikret. "Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique." Turkish journal of urology vol. 44,1 (2018): 16-23. doi: https://doi.org/10.5152/tud.2017.95752
Gevrek F, Erdemir F. Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique. Turk J Urol. 2018 Jan;44(1):16-23. doi: 10.5152/tud.2017.95752. Epub 2018 Jan 08. PMID: 29484222; PMCID: PMC5821277.
Copy Download .nbib Format: NLM
Share it on

Turk J Urol. 2018 Jan;44(1):16-23. doi: 10.5152/tud.2017.95752. Epub 2018 Jan 08.

Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique.

Turkish journal of urology

Fikret Gevrek, Fikret Erdemir

Affiliations

  1. Department of Histology and Embryology, Gaziosmanpasa University, Tokat, Turkey.
  2. Department of Urology, Gaziosmanpasa University, Tokat, Turkey.

PMID: 29484222 PMCID: PMC5821277 DOI: 10.5152/tud.2017.95752

Abstract

OBJECTIVE: Cisplatin is an effective antineoplastic agent used in cancer therapy. However, the use of cisplatin is restricted due to its toxic side effects. Alleviation of its side effects which restricts cisplatin use is highly important. We aimed to investigate the effects of curcumin, vitamin E and their combination in cisplatin induced testicular apoptosis.

MATERIAL AND METHODS: Thirty-five Wistar albino male adult rats, weighing 300-350 g were divided randomly into five groups including seven rats in each as control, cisplatin, curcumin, vitamin E, and curcumin + vitamin E. On the posttest 5

RESULTS: Increased histological damage with cisplatin administration was reduced in treatment, especially in combination therapy. Cas-3 and Bax protein immunostaining intensities H-scores were significantly increased but Bcl-2 was slightly decreased in the cisplatin group compared to the control. In all treatment groups Bax, Cas-3 decreased compared to cisplatin group however Bcl-2 decreased in the curcumin and vitamin E groups. Bax/Bcl-2 was the highest in the cisplatin, and decreased in all treatment groups in favor of control.

CONCLUSION: Cas-3 expression increased by cisplatin administration suggests that cisplatin causes apoptosis of germ cells. According to the present findings, cisplatin mainly caused testicular apoptosis through the Cas-3 and Bax apoptotic protein pathways. Cisplatin-induced testicular apoptosis can be prevented by administration of curcumin, vitamin E, and combination therapy.

Keywords: Apopitozis; cisplatin; curcumin; immunohistochemistry; testis; vitamin E

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

References

  1. Andrologia. 2015 Mar;47(2):194-208 - PubMed
  2. Oxid Med Cell Longev. 2008 Oct-Dec;1(1):15-24 - PubMed
  3. Eur J Obstet Gynecol Reprod Biol. 2004 Apr 5;113 Suppl 1:S2-6 - PubMed
  4. Braz J Otorhinolaryngol. 2009 Sep-Oct;75(5):745-52 - PubMed
  5. Free Radic Biol Med. 2007 Aug 15;43(4):568-80 - PubMed
  6. Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2231-7 - PubMed
  7. J Natl Cancer Inst Monogr. 2005;(34):6-8 - PubMed
  8. Int J Pediatr Otorhinolaryngol. 2016 Oct;89:173-8 - PubMed
  9. Genetics. 2015 Aug;200(4):1003-14 - PubMed
  10. Anat Rec (Hoboken). 2008 Jul;291(7):797-808 - PubMed
  11. Otol Neurotol. 2014 Aug;35(7):1131-9 - PubMed
  12. Cancer Chemother Pharmacol. 2012 Jan;69(1):207-13 - PubMed
  13. Otol Neurotol. 2014 Jun;35(5):e169-77 - PubMed
  14. Mutat Res. 2009 Apr 30;675(1-2):29-34 - PubMed
  15. Redox Biol. 2014;2:165-9 - PubMed
  16. Exp Toxicol Pathol. 2016 Apr;68(4):197-204 - PubMed
  17. J Androl. 2009 May-Jun;30(3):280-6 - PubMed
  18. J Neurol Sci. 2008 Nov 15;274(1-2):48-53 - PubMed
  19. J Laryngol Otol. 2012 May;126(5):464-9 - PubMed
  20. Biochem Pharmacol. 2010 Dec 1;80(11):1613-31 - PubMed
  21. Laryngoscope. 2004 Mar;114(3):538-42 - PubMed
  22. Med Oncol. 2011 Jun;28(2):615-21 - PubMed
  23. Andrologia. 2015 Sep;47(7):793-800 - PubMed
  24. Cancer Chemother Pharmacol. 2016 Apr;77(4):875-9 - PubMed
  25. Int J Pediatr Otorhinolaryngol. 2012 Mar;76(3):404-8 - PubMed
  26. Head Neck. 2016 Apr;38 Suppl 1:E2118-21 - PubMed
  27. Int J Pediatr Otorhinolaryngol. 2017 Aug;99:100-106 - PubMed

Publication Types